Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-05-02
1999-02-09
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514909, 514910, A61K 3144
Patent
active
058695036
ABSTRACT:
A therapeutic method is provided to alleviate the tobacco withdrawal syndrome, the symptoms of nicotine withdrawal or the management of human body weight in nicotine-experienced or nicotine-naive individuals, comprising of administering an amount of nicotine metabolites or a pharmaceutically acceptable salts thereof to a human in need of such treatment, in an amount which is effective to reduce or eliminate at least one of the symptoms of the tobacco withdrawal syndrome, nicotine withdrawal or manage human body weight.
REFERENCES:
patent: 3048520 (1962-08-01), McKennis et al.
patent: 3867519 (1975-02-01), Michaels
patent: 3870791 (1975-03-01), Haddad et al.
patent: 3870794 (1975-03-01), Hutchinson et al.
patent: 4051842 (1977-10-01), Hazel et al.
patent: 4136177 (1979-01-01), Lin et al.
patent: 4140122 (1979-02-01), Kuhl et al.
patent: 4255415 (1981-03-01), Chrai et al.
patent: 4383529 (1983-05-01), Webster
patent: 4621074 (1986-11-01), Bourne
patent: 4668506 (1987-05-01), Bawa
patent: 4713244 (1987-12-01), Bawa et al.
patent: 4748181 (1988-05-01), Hutchinson et al.
patent: 4788063 (1988-11-01), Fisher et al.
patent: 4835162 (1989-05-01), Abood
patent: 4931279 (1990-06-01), Bawa et al.
patent: 4946853 (1990-08-01), Bannon et al.
patent: 4966916 (1990-10-01), Abood
patent: 5278176 (1994-01-01), Lin
Rylander, E. et al., "Exposure to Environmental Tobacco Smoke and Urinary Excretion of Cotinine and Nicotine in Children," Acta Poediatr. Scand. 78: 449-450 (1989).
HCAplus Abstract 1991-116773 (Document No. 114: 116773), 1991, Perkins et al.
R. Barbieri et al, "Nicotine, Cotinine and Anabasine Inhibit Aromatase in Human Trophoblast in Vitro", J. Clin. J. Steroid Invest., 77:1727-1733 (1986).
R. Barbieri et al, "Nicotine, Cotinine and Anabasine on Rat Adrenal 11B-hydroxylase and 21-hydroxylase", J. Steroid Biochem., 28: 25-28 (1987).
R. Barbieri, et al, "Cotinine and Nicotine Inhibit Human Fetal Adrenal 11B-hydroxylase", Journal of Clinical Endocrinology and Metabolism, 69:1221-1224 (1989).
N. Benowitz et al, "Cotinine Disposition and Effects", Clin. Pharmacol. Ther., 34:604-611 (1983).
N. Benowitz et al, "Inverse Relation Between Serum Cotinine Concentration and Blood Pressure in Cigarette Smokers", Circulation, 80:1309-1312 (1989).
J. Borzelleca et al, "Studies on the Respiratory and Cardiovascular Effects of (-)-Cotinine", J. Pharm. Exper. Therapeutics, 137:313-318 (1962).
K. Bauman et al, "Validity of Self-Reports of Smokeless Tobacco Use and Validity of Cotinine as an Indicator of Cigarette Smoking", The American Journal of Epidemiology, 130:327-337 (1989).
E. Bowman et al, "(-)-Cotinine", Biochemical Preparations, 10:36-39 (1963).
E. Bowman et al, "Disposition and Fate of (-)-Cotinine in the Mouse", The Journal of Pharmacology and Experimental Therapeutics, 143:301-308 (1963).
E. Bowman et al, "Studies on the Metabolism of (-)-Cotinine in the Human", J. Pharmacol. Exp. Ther., 135:306-311 (1962).
R. Chahine et al, "The in Vitro Effects of Nicotine and Cotinine on Prostacyclin and Thromboxane Biosynthesis", Prostaglandins, Leukotrienes, and Essential Fatty Acids, 40:261-266 (1990).
M. Curvall et al, "Simulation and Evaluation of Nicotine Intake During Passive Smoking: Cotinine Measurements in Body Fluids of Nonsmokers Given Intravenous Infusions of Nicotine", Clinical Pharmacol Therapy, 47:42-49 (1990).
M. Curvall et al, "The Pharmacokinetics of Cotinine in Plasma and Saliva from Non-Smoking Healthy Volunteers", The European Journal of Clinical Pharmacology, 38:281-287 (1990).
E. Di Giusto et al, "Some Properties of Saliva Cotinine Measurements in Indicating Exposure to Tobacco Smoking", The American Journal of Public Health, 76:1245-1246 (1986).
P. DeSchepper et al, "Kinetics of Cotinine After Oral and Intravenous Administration to Man", The European Journal of Clinical Pharmacology, 31:583-588 (1987).
J. Gabrielsson et al, "Constant-Rate Infusion of Nicotine and Cotinine. I. A Physiological Pharmacokinetic Analysis of the Cotinine Disposition, and Effects on Clearance and Distribution in the Rat", The Journal of Pharmacokinetics and Biopharmaceutics, 15:583-599 (1987).
R. Galeazzi et al, "Steady-Stroke Concentration of Cotinine as a Measure of Nicotine-Intake by Smokers", The European Journal of Clinical Pharmcology, 28:301-304 (1985).
D. Glenn et al, "Synthesis and Mass Spectrometry of Some Structurally Related Nicotinoids", The Journal of Organic Chemistry, 43:2860-2870 (1978).
S. Goldberg et al, "Nicotine and Some Related Compounds: Effects on Schedule-Controlled Behavior and Discriminative Properties in Rats", Psychopharmacology, 97:295-302 (1989).
R. Hutchinson et al, "Effects of Nicotine on Avoidance, Conditioned Suppression and Aggression Response Measures in Animals and Man", 171-196.
P. Jacob et al, "Disposition Kinetics of Nicotine and Cotinine Enantiomers in Rabbis and Beagle Dogs", The Journal of Pharmaceutical Sciences, 77:396-400 (1988).
L. Jarczyk et al, "Serum and Saliva Concentration of Cotinine in Smokers and Passive Smokers", The Journal of Clinical Chemical Biochemistry, 27:230-231 (1989).
M. Jarvis et al, "Biochemical Markers of Smoke Absorption and Self Reported Exposure to Passive Smoking", The Journal of Epidemiology and Community Health, 38:335-339 (1984).
J. Jordanov, "Cotinine Concentrations in Amniotic Fluid and Urine of Smoking, Passive Smoking and Non-Smoking Pregnant Women at Term and in the Urine of Their Neonates on 1st Dat of Life", The European Journal of Pediatrics, 149:734-737 (1990).
K. Kim et al, "Effects of Some Nicotine Metabolites and Related Coupounds on Isolated Smooth Muscle", The Journal of Pharmacology and Experimental Therapeutics, 161:59-69 (1968).
B. Kuo et al, "Influence of Nicotine and Cotinine on the Expression of Plasminogen Activator Activity in Bovine Aortic Endothelial Cells", Thrombosis and Haemostasis, 61:70-76 (1989).
G. Kyerematen et al, "Disposition of Nicotine and Eight Metabolites in Smokers and Nonsmokers: Identification in Smokers of Two Metabolites That are Longer Lived Than Cotinine", Clinical Pharmacol Ther., 48:641-651 (1990).
W. Luck et al, "Extent of Nicotine and Cotinine Transfer to the HUman Fetus, Placenta and Amniotic Fluid of Smoking Mothers", Dev. Pharmacol. Ther., 8:384-395 (1985).
C. Lynch et al, "Spontaneous Cigarette Brand Switching: Consequences for Nicotine and Carbon Monoxide Exposure", The American Journal of Public Health, 78:1191-1194 (1987).
H. McKennis et al, "Demethylation of Cotinine in Vivo", Demethylation of Cotinine in Vivo, 81:3951-3954 (1959).
H. McKennis et al, "Alternate Routes in the Metabolic Degradation of the Pyrrolidine Ring of Nicotine", The Journal of Biological Chemistry, 239:3990-3996 (1964).
A. Meikle et al, "Nicotine and Cotinine Effects on 3 Alpha Hydroxysteroid Dehydrogenase in Canine Prostate", Life Sciences, 43:1845-1850 (1988).
A. McNeill et al, "Saliva Cotinine as an Indicator of Cigarette Smoking in Adolescents", The British Journal of Addiction, 82:1355-1360 (1987).
M. Noland et al, "Saliva Cotinine and Thiocyanate: Chemical Indicators of Smokeless Tobacco and Cigarette Use in Adolecents", The Journal of Behavioral Medicine, 11:423-433 (1988).
M. Risner et al, "Effects of Nicotine, Cocaine and Some of Thier Metabolites on Schedule-Controlled Responding by Beagle Dogs and Squirrel Monkeys", The Journal of Pharmacology and Experimental Therapeutics, 234:113-119 (1985).
I. Sasson et al, "Cigarette Smoking and Neoplasia of the Uterine Cervix: Smoke Constituents in Cervical Mucus", The New England Journal of Medicine, 312:315-316 (1985).
G. Scherer et al, "Pharmacokinetics of Nicotine, Cotinine and 3'-Hydroxycotinine in Cigarette Smokers", Klin Wochenschr, 66:5-11 (1988).
S. Schwartz et al, "Studies on the Degradation of the Pyrrolidine Ring of (-)-Nicotine in Vivo", The Journal of Biological Chemistry, 238:1807-1812 (1963).
D. Sepkovic et al, "Biomedical Applications of Cotinine Quantitation in Smoking Related Research", Public Health Briefs, The American Journal of Public Health, 75:663-665 (1985).
Surgeon General, "The Health Consequences of Smoking -- Nicotine A
Cintins Marianne M.
Moezie M.
LandOfFree
Nicotine metabolites and human body weight does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nicotine metabolites and human body weight, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nicotine metabolites and human body weight will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1948655